Neuland Laboratories Ltd. (NEULANDLAB) Share Price Hits Fresh 52-Week High

Neuland Laboratories Ltd. Share Price traded at Rs 23,296.55, down 1.59% on the day, after touching a fresh 52-week high of Rs 23,850. Market capitalisation stood at Rs 29,908.4 crore.

Neuland Laboratories Ltd. Share Price was at Rs 23,296.55 on 18 August 2026, down 1.59% from the previous close of Rs 23,672.45, after the stock touched a fresh 52-week high of Rs 23,850 during the session. The company’s market capitalisation stood at Rs 29,908.4 crore, placing it among the larger listed names tracked in this Healthcare screen. For investors searching for Neuland Laboratories Ltd. Share Price Today, the key data point is that the stock hit a new one-year high intraday even though it later traded below that peak.

The supplied data confirms the price event clearly: the stock opened at Rs 23,650, rose to Rs 23,850, and then moved to the day low of Rs 23,296.55. Turnover was Rs 2.91 crore with current volume of 1,248 shares. That makes Neuland Laboratories Ltd. Stock News relevant in today’s market because fresh 52 Week High Stocks often draw attention from traders and longer-term market participants tracking price action, valuation and relative positioning.

What is also notable is that the verified data does not establish a company-specific catalyst. So, while Neuland Laboratories Ltd. Share Price is trending because of the fresh yearly high, the evidence available here supports the price event itself rather than a confirmed reason behind it. In this Univest stock analysis, the focus therefore shifts to what today’s move says about price behaviour, how the valuation compares with the Healthcare benchmark, and where the company stands against listed peers.

Neuland Laboratories Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 23,296.55
Previous Close	Rs 23,672.45
Today's Change	Rs -375.9 (-1.59%)
Day Open	Rs 23,650
Fresh 52-Week High	Rs 23,850
Day Low	Rs 23,296.55
Current Volume	1,248
Turnover	Rs 2.91 crore
Market Capitalisation	Rs 29,908.4 crore

Neuland Laboratories Ltd. (NEULANDLAB) traded at Rs 23,296.55. versus the previous close of Rs 23,672.45, a fall of 1.59%. The stock opened at Rs 23,650, reached Rs 23,850, touched Rs 23,296.55. Reported volume was 1,248.

Neuland Laboratories Ltd. Share Price Today shows a stock that marked a fresh 52-week high intraday at Rs 23,850 but then gave up part of that strength and was last seen at Rs 23,296.55. The session still stands out because the one-year high was renewed during live trade.

From a pure price-action perspective, the session was active and eventful. Neuland Laboratories Ltd. Share Price opened at Rs 23,650 against a previous close of Rs 23,672.45, indicating a near-flat start. It then climbed to Rs 23,850, which became the new 52-week peak, before slipping to Rs 23,296.55, also the day’s low. That leaves the stock down Rs 375.9 or 1.59% for the day at the latest supplied price, despite registering the fresh high earlier in the session.

This kind of intraday pattern matters for anyone tracking Neuland Laboratories Ltd. Share Price Live or looking at Stocks in News and Market Movers. The stock created a new one-year high, but the closing-level snapshot in the data shows that gains at the top were not fully sustained. Turnover came in at Rs 2.91 crore and current volume stood at 1,248 shares, which places the move firmly on the radar for investors monitoring Trading Volume alongside price levels.

For Neuland Laboratories Ltd. Share News, the most factual takeaway is simple: the market established a higher yearly price point at Rs 23,850. Even with the stock later below that mark, the 52-week high event itself can keep the counter in focus across NSE News, BSE News and broader Stock Market Today screens. The next step is to examine whether fundamentals support the attention the stock is getting.

Neuland Laboratories Ltd. (NEULANDLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 29,908.4 crore
P/E Ratio	170.32x
P/B Ratio	0.42x
ROE	-2.89%
ROCE	-0.26%

Neuland Laboratories Ltd. was valued at a P/E ratio of 170.32x, a P/B ratio of 0.42x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	170.32x
Benchmark Median P/E	21x
Benchmark Average P/E	49.19x
Benchmark P/E Range	0x to 1,598.54x
Company P/B Ratio	0.42x
Benchmark Median P/B	1.9x
Company ROE	-2.89%
Benchmark Median ROE	10.92%
Company ROCE	-0.26%
Benchmark Median ROCE	13.29%
Company Market Capitalisation	Rs 29,908.4 crore
Benchmark Median Market Cap	Rs 136.28 crore

Neuland Laboratories Ltd. (NEULANDLAB) is classified under sector: Healthcare.

Neuland Laboratories Ltd. (NEULANDLAB) has a P/E ratio of 170.32x, which is above the benchmark median of 21x, a difference of +711.05%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Neuland Laboratories Ltd. (NEULANDLAB) has a ROE of -2.89%, which is below the benchmark median of 10.92%, a difference of -126.47%. Neuland Laboratories Ltd. (NEULANDLAB) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,985.15	170.32	0.42	-2.89	-0.26
Beta Drugs Ltd.	BETA	2,827.67	65.02	10.29	18.65	22.17
Ind-Swift Laboratories Ltd.	INDSWFTLAB	2,645.37	47.53	1.82	-0.78	8.31
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,562.17	33.62	6.93	-2.6	16.92
Fredun Pharmaceuticals Ltd.	FREDUN	2,559.68	54.85	8.19	11.42	13.15

Neuland Laboratories Ltd. (NEULANDLAB) has a P/E ratio of 170.32x compared with the displayed peer median of 54.85x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of -0.78% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. Neuland Laboratories Ltd. (NEULANDLAB) has a market capitalisation of Rs 29,908.4 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Neuland Laboratories Ltd.

This stock is attracting attention because the verified data combines a fresh one-year high with unusual valuation and sector positioning. For investors following Breakout Stocks, Momentum Stocks and 52 Week High Stocks, several facts stand out at once.

• Fresh 52-week high: the stock touched Rs 23,850 during the session, setting a new yearly high.
• Current trading level: Neuland Laboratories Ltd. Share Price was Rs 23,296.55, down 1.59% from the previous close of Rs 23,672.45.
• Session range: the stock opened at Rs 23,650 and moved between Rs 23,296.55 and Rs 23,850.
• Activity snapshot: turnover was Rs 2.91 crore with current volume of 1,248 shares.
• Valuation mix: P/E stands at 170.32, while P/B is 0.42.
• Profitability context: ROE is -2.89% and ROCE is -0.26%.
• Sector benchmark: the P/E is above the Healthcare median of 21 and average of 49.19 across 196 companies.
• Scale: market capitalisation of Rs 29,908.4 crore is well above the peer market-cap figures supplied.

About Neuland Laboratories Ltd.

Neuland Laboratories Ltd. is a listed company tracked under the Healthcare sector in the supplied market dataset. For investors monitoring Neuland Laboratories Ltd. Company News, the current market discussion is centred on its share price behaviour, market capitalisation and relative valuation within this sector screen rather than on a separately verified operating update in the supplied data.

The available company context here is sector-led rather than business-description-led. The stock is listed under the Healthcare grouping, and the peer and benchmark sets supplied alongside it include pharmaceutical and healthcare companies. That makes Neuland Laboratories Ltd. relevant in sector-wide screens used by investors to compare valuation, profitability and stock performance across related listed names. In today’s context, the company is drawing attention because it entered the list of stocks making a fresh 52-week peak. On Univest, this places the stock in a category often followed by users looking at price action, sector comparison, peer benchmarking and broader market trends.

Track Neuland Laboratories Ltd. Share Price on Univest

Use Neuland Laboratories Ltd. (NEULANDLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors tracking Neuland Laboratories Ltd. Share Price can use Univest to follow live share price moves, 52-week levels, market capitalisation, valuation ratios, sector comparisons and peer benchmarks in one place. For users searching Neuland Laboratories Ltd. Share Price Today or Neuland Laboratories Ltd. Latest News, that makes it easier to connect intraday price action with fundamental context.

Univest also helps users monitor stock analysis inputs such as price range, turnover, market cap and the broader Healthcare benchmark. When Neuland Laboratories Ltd. Share Price appears in Stock Updates or Market Movers screens after touching a fresh yearly high, readers can use Univest to keep track of how the move compares with peers and sector averages over time.

Frequently Asked Questions

What is Neuland Laboratories Ltd. Share Price today?

Ans. Neuland Laboratories Ltd. Share Price today was Rs 23,296.55 at the latest supplied snapshot. The stock was down 1.59% or Rs 375.9 from the previous close of Rs 23,672.45 after touching a fresh 52-week high intraday.

What was the fresh 52-week high for Neuland Laboratories Ltd. today?

Ans. Neuland Laboratories Ltd. touched a fresh 52-week high of Rs 23,850 during the session. The stock opened at Rs 23,650 and later traded at Rs 23,296.55, showing that the yearly high was set intraday before some pullback.

Why is Neuland Laboratories Ltd. Share Price in the news today?

Ans. Neuland Laboratories Ltd. Share Price is in the news because it registered a fresh one-year high of Rs 23,850. The supplied data confirms the price event, while turnover of Rs 2.91 crore and volume of 1,248 shares kept it in.

What was the day range for Neuland Laboratories Ltd. Share Price?

Ans. The day range for Neuland Laboratories Ltd. Share Price was Rs 23,296.55 to Rs 23,850. The stock opened at Rs 23,650, moved up to a fresh 52-week peak, and later slipped back to the session low by the latest reading.

What is the market capitalisation of Neuland Laboratories Ltd.?

Ans. Neuland Laboratories Ltd. had a market capitalisation of Rs 29,908.4 crore in the supplied data. That figure is far above the Healthcare sector benchmark median of Rs 136.28 crore and average of Rs 468.36 crore shown here.

What are the P/E and P/B ratios of Neuland Laboratories Ltd.?

Ans. Neuland Laboratories Ltd. is trading at a P/E ratio of 170.32 and a P/B ratio of 0.42. In the supplied Healthcare benchmark, the median P/E is 21 while the median P/B is 1.9 across 196 companies.

How do ROE and ROCE look for Neuland Laboratories Ltd.?

Ans. The supplied profitability ratios show ROE at -2.89% and ROCE at -0.26% for Neuland Laboratories Ltd. Both figures are below the Healthcare sector medians of 10.92% for ROE and 13.29% for ROCE in this dataset.

How does Neuland Laboratories Ltd. compare with Healthcare sector valuation benchmarks?

Ans. On valuation, Neuland Laboratories Ltd. shows a mixed profile. Its P/E of 170.32 is above the sector median of 21 and average of 49.19, while its P/B of 0.42 is below the sector median of 1.9.

How does Neuland Laboratories Ltd. compare with listed peers?

Ans. Compared with peers such as Beta Drugs, Ind-Swift Laboratories, Dr Agarwals Eye Hospital and Fredun Pharmaceuticals, Neuland Laboratories Ltd. has a higher P/E than most shown, a lower P/B, and a much larger market capitalisation.

What should investors monitor next in Neuland Laboratories Ltd. Share Price?

Ans. Investors can monitor whether Neuland Laboratories Ltd. Share Price holds attention after touching Rs 23,850, along with turnover, volume, and how its P/E of 170.32 and negative ROE and ROCE compare with sector and peer benchmarks.